LUNG

2.00

13.64% 0.24

Dopo l'orario di chiusura: 2.03 0.03 +1.50%

Pulmonx Corp (LUNG)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.76

Aprire:

$1.76

Volume 24 ore:

2.10M

Relative Volume:

0.91

Capitalizzazione di mercato:

$81.49M

Reddito:

$68.68M

Utile/perdita netta:

$-60.84M

Rapporto P/E:

-1.25

EPS:

-1.6

Flusso di cassa netto:

$-38.42M

1 W Prestazione:

+21.95%

1M Prestazione:

+23.46%

6M Prestazione:

-58.59%

1 anno Prestazione:

-68.00%

Intervallo 1D:

$1.74

$2.10

Intervallo di 1 settimana:

$1.56

$2.89

Portata 52W:

$1.47

$9.37

Pulmonx Corp Stock (LUNG) Company Profile

Nome

Pulmonx Corp

Settore

Healthcare (1135)

Industria

Medical Devices (144)

Telefono

650-364-0400

Indirizzo

700 CHESAPEAKE DRIVE, REDWOOD CITY

Dipendente

291

Cinguettio

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

LUNG's Discussions on Twitter

Confronta LUNG con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LUNG Pulmonx Corp	2.00	71.71M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	123.62	216.79B	43.84B	13.90B	6.78B	7.9725
BSX Boston Scientific Corp	100.72	149.02B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	356.24	141.06B	23.82B	2.92B	4.02B	7.5574
MDT Medtronic Plc	90.70	116.68B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	82.45	49.01B	5.69B	1.41B	577.90M	6.9828

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-31	Downgrade	Piper Sandler	Overweight → Neutral
2025-03-10	Iniziato	D. Boral Capital	Buy
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-06-04	Iniziato	Lake Street	Buy
2024-02-23	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-09-05	Iniziato	Craig Hallum	Buy
2023-02-27	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-01-03	Downgrade	BofA Securities	Neutral → Underperform
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-07-11	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Neutral
2021-12-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-04-01	Iniziato	Citigroup	Buy
2021-03-25	Iniziato	Piper Sandler	Neutral
2021-03-10	Aggiornamento	BofA Securities	Neutral → Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-10-26	Iniziato	BofA Securities	Buy
2020-10-26	Iniziato	Canaccord Genuity	Buy
2020-10-26	Iniziato	Morgan Stanley	Equal-Weight
2020-10-26	Iniziato	Stifel	Buy
2020-10-26	Iniziato	Wells Fargo	Equal Weight

Mostra tutto

Pulmonx Corp Borsa (LUNG) Ultime notizie

Oct 31, 2025

Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Insider Monkey

Oct 31, 2025

Is Pulmonx Corporation reversing from oversold territoryWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025

Historical volatility pattern of Pulmonx Corporation visualizedChart Signals & High Accuracy Swing Trade Signals - newser.com

Oct 31, 2025

Oct 29, 2025

Why Pulmonx Corporation stock remains on watchlistsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Oct 29, 2025

Is this a good reentry point in Pulmonx CorporationJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com

Oct 29, 2025

Pulmonx (NASDAQ:LUNG) Given New $14.00 Price Target at D. Boral Capital - MarketBeat

Oct 29, 2025

Pulmonx (LUNG) Anticipates Q3 Revenue of $21.5 Million - GuruFocus

Oct 29, 2025

What hedge fund activity signals for Pulmonx Corporation stockRecession Risk & Daily Profit Maximizing Tips - newser.com

Oct 29, 2025

Tick level data insight on Pulmonx Corporation volatilityMarket Activity Summary & Entry Point Strategy Guides - newser.com

Oct 29, 2025

Oct 28, 2025